Form 4: Edgewell Executive Granted 26,476 Equity Awards

Sentiment:

Insider Transaction Report


Edgewell Personal Care Co. President, North America, Jessica Spence, was granted 26,476 restricted stock units vesting over three years.

Summary

  • Jessica Spence, President, North America, and an Officer of Edgewell Personal Care Co. (EPC), acquired 26,476 derivative securities.
  • The transaction date for this acquisition was November 14, 2025.
  • These derivative securities are Restricted Stock Units (RSEs) with a conversion or exercise price of $0.
  • One-third of the RSEs will vest and convert into shares of Edgewell common stock on November 14, 2026, November 14, 2027, and November 14, 2028.
  • Vesting is conditional upon Jessica Spence's continued employment on the specified dates.
  • A portion or all of the RSEs may also vest upon death, disability, a change in control, or certain termination events.
  • Following this transaction, Jessica Spence beneficially owns 26,476 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of equity to a key executive is generally a positive event, aligning management incentives with shareholder interests and aiding in executive retention. It is a routine compensation practice.

Positives

  • The grant of restricted stock units aligns the executive's interests with those of shareholders, incentivizing long-term performance.
  • Equity compensation is a standard practice for retaining key management personnel.

Negatives

  • The future conversion of RSEs into common stock will result in minor dilution for existing shareholders.

Risks

  • The vesting of the RSEs is contingent on continued employment, meaning the executive may forfeit unvested awards if employment ceases under certain conditions.
  • The value of the vested shares is subject to the future market price of Edgewell common stock.

Future Outlook

The future outlook for the granted equity is tied to the executive's continued employment and the company's performance, which will influence the stock price and the ultimate value of the vested shares.

Industry Context

The grant of restricted stock units to a senior executive is a common practice across various industries, including consumer goods, to incentivize leadership and align their financial interests with long-term company performance and shareholder value.

Stakeholder Impact

  • Shareholders: Potential for minor future dilution upon vesting, but also improved alignment of executive incentives with long-term shareholder value.
  • Executive (Jessica Spence): Receives long-term equity incentive, contingent on performance and continued employment.

Next Steps

  • The RSEs will vest in three equal annual installments on November 14, 2026, 2027, and 2028, subject to employment conditions.

Key Dates

DateDescription
11/14/2025Transaction date for the acquisition of derivative securities.
11/14/2026First vesting date for one-third of the RSEs.
11/14/2027Second vesting date for one-third of the RSEs.
11/14/2028Third and final vesting date for one-third of the RSEs.
11/17/2025Signature date of the reporting person on the filing.

Keywords

Edgewell Personal Care, EPC, Jessica Spence, Restricted Stock Units, RSEs, Executive Compensation, Insider Transaction, Equity Grant, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.